DE69021396D1 - Tabakersatz. - Google Patents

Tabakersatz.

Info

Publication number
DE69021396D1
DE69021396D1 DE69021396T DE69021396T DE69021396D1 DE 69021396 D1 DE69021396 D1 DE 69021396D1 DE 69021396 T DE69021396 T DE 69021396T DE 69021396 T DE69021396 T DE 69021396T DE 69021396 D1 DE69021396 D1 DE 69021396D1
Authority
DE
Germany
Prior art keywords
tobacco replacement
tobacco
replacement
cyclodexstrincompound
nicotin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69021396T
Other languages
English (en)
Other versions
DE69021396T3 (de
DE69021396T2 (de
Inventor
Thommy Carlsson
Sven Andersson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
McNeil AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20377819&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69021396(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of DE69021396D1 publication Critical patent/DE69021396D1/de
Application granted granted Critical
Publication of DE69021396T2 publication Critical patent/DE69021396T2/de
Publication of DE69021396T3 publication Critical patent/DE69021396T3/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G3/00Sweetmeats; Confectionery; Marzipan; Coated or filled products
    • A23G3/34Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
    • A23G3/36Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
    • A23G3/364Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G3/368Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G4/00Chewing gum
    • A23G4/06Chewing gum characterised by the composition containing organic or inorganic compounds
    • A23G4/12Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G4/126Chewing gum characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing vitamins, antibiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
DE69021396T 1989-12-21 1990-12-18 Tabakersatz. Expired - Fee Related DE69021396T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8904295A SE8904295D0 (sv) 1989-12-21 1989-12-21 Smoking substitute
PCT/SE1990/000848 WO1991009599A1 (en) 1989-12-21 1990-12-18 Smoking substitute

Publications (3)

Publication Number Publication Date
DE69021396D1 true DE69021396D1 (de) 1995-09-07
DE69021396T2 DE69021396T2 (de) 1996-04-04
DE69021396T3 DE69021396T3 (de) 2000-08-31

Family

ID=20377819

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69021396T Expired - Fee Related DE69021396T3 (de) 1989-12-21 1990-12-18 Tabakersatz.

Country Status (10)

Country Link
EP (1) EP0506774B2 (de)
JP (1) JP3210945B2 (de)
AT (1) ATE125705T1 (de)
AU (1) AU6977491A (de)
DE (1) DE69021396T3 (de)
DK (1) DK0506774T4 (de)
ES (1) ES2075423T5 (de)
GR (2) GR3017486T3 (de)
SE (1) SE8904295D0 (de)
WO (1) WO1991009599A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
SE9002052D0 (sv) * 1990-06-08 1990-06-08 Pharmacia Ab Smoking composition
ATE241984T1 (de) * 1993-03-26 2003-06-15 Franciscus Wilhelmus He Merkus Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
AU717600B2 (en) * 1993-07-26 2000-03-30 Mcneil Ab Improved nicotine lozenge and therapeutic method for smoking cessation
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
EP0906089B1 (de) 1996-05-13 2003-08-27 Novartis Consumer Health S.A. Mundfreisetzungssystem
US5760049A (en) * 1997-02-21 1998-06-02 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US6166032A (en) * 1997-02-07 2000-12-26 Synapse Pharmaceuticals International, Inc. Method for controlling tobacco use and alleviating withdrawal symptoms due to cessation of tobacco use
US6211194B1 (en) 1998-04-30 2001-04-03 Duke University Solution containing nicotine
WO2004056363A2 (en) * 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
CN100584385C (zh) * 2003-07-10 2010-01-27 协和发酵生化株式会社 片剂及其制备方法
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
JP4931596B2 (ja) 2003-11-07 2012-05-16 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
JP5215175B2 (ja) * 2005-05-25 2013-06-19 ユーエス スモークレス タバコ カンパニー リミテッド ライアビリティ カンパニー タバコ組成物
US20070267033A1 (en) 2006-02-09 2007-11-22 Philip Morris Usa Inc. Gamma cyclodextrin flavoring-release additives
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
GB0700889D0 (en) * 2007-01-17 2007-02-21 British American Tobacco Co Tobacco, tobacco derivative and/or tobacco substitute products, preparation and uses thereof
PT2177213E (pt) * 2008-09-17 2013-02-21 Siegfried Ltd Granulado contendo nicotina
AU2009303979A1 (en) * 2008-10-14 2010-04-22 Mcneil Ab Multi portion intra-oral dosage form and use thereof
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
JPS5312600B2 (de) * 1974-06-21 1978-05-02
GB2142822B (en) * 1983-06-29 1987-02-11 Alec Stanley Walter Shaw Nicotine lozenges
IL73912A0 (en) * 1984-01-09 1985-03-31 Advanced Tobacco Prod Nicotine preparation
FR2608156B1 (fr) * 1986-12-12 1988-12-30 Ethypharm Sa Chewing-gum pour se liberer du tabac

Also Published As

Publication number Publication date
DE69021396T3 (de) 2000-08-31
DK0506774T4 (da) 2000-12-04
WO1991009599A1 (en) 1991-07-11
ES2075423T5 (es) 2000-05-16
GR3017486T3 (en) 1995-12-31
EP0506774B2 (de) 2000-03-22
EP0506774B1 (de) 1995-08-02
DK0506774T3 (da) 1995-11-13
SE8904295D0 (sv) 1989-12-21
DE69021396T2 (de) 1996-04-04
JP3210945B2 (ja) 2001-09-25
ATE125705T1 (de) 1995-08-15
EP0506774A1 (de) 1992-10-07
JPH05504949A (ja) 1993-07-29
GR3033405T3 (en) 2000-09-29
AU6977491A (en) 1991-07-24
ES2075423T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
DE69021396D1 (de) Tabakersatz.
DK69488D0 (da) Cigaret
FI900381A0 (fi) Foerbaettringar till tobaksprodukter.
SE8304966D0 (sv) Oral komposition
SE8803082D0 (sv) Improvements relating to smoking articles
SE8803081D0 (sv) Improvements relating to smoking articles
BR9106538A (pt) Cartucho para um inalador de nicotina e processo para preparar um cartucho para um inalador de nicotina
NO914769D0 (no) Traadformet aromafrigjoerende tilsetning for roeketobakksblanding
BR8304191A (pt) Aparelho e processo de formar uma haste de material de fumar e cigarro
FR2615752B1 (fr) Fabrication de filtres de fumee de tabac
AR222255A1 (es) Tabaco de fumar
DE69030471T2 (de) Rauchartikel
IT1183629B (it) Procedimento fabbricare tabacco ricostituito
MD217B1 (ro) Compozitie pentru aromatizarea tutunului de fumat
MD216B1 (ro) Compozitie pentru aromatizarea tutunului de fumat
FR2632496B1 (fr) Cigares et cigarillos a tabac blond
FR2565824B1 (fr) Composition d'ambiance, frenatrice de l'envie de fumer du tabac
FR2659532B3 (fr) Destructeur de megots de cigarettes ou de cigares.
BR6702382U (pt) Cigarro artificial,inibidor de vicio de fumar
IT8302110A0 (it) Pinza per fumare sigari e sigarette
ES294143Y (es) Protector para la caida de la ceniza de cigarros y cigarrillos
IT216196Z2 (it) Bocchino da fumo per sigari e sigarette ed inserto parafuoco e portafiltro dello stesso.
GEP19960658B (en) Smoking article
IT8164501A0 (it) Spegnimento rapido, inodoro, di mozziconi di sigaro e sigaretta.
KR900009507U (ko) 권연 담배

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: PHARMACIA & UPJOHN AB, STOCKHOLM, SE

8327 Change in the person/name/address of the patent owner

Owner name: PFIZER HEALTH AB, STOCKHOLM, SE

8327 Change in the person/name/address of the patent owner

Owner name: PFIZER CONSUMER HEALTHCARE HELTH AB, STOCKHOLM, SE

8339 Ceased/non-payment of the annual fee